Suhail A. Ansari

Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer

Özge Saatci, Aysegül Kaymak, Umar Raza et al. · Nature Communications · 2020 · 346 citations · Full text

miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer

Merve Mutlu, Özge Saatci, Suhail A. Ansari et al. · Scientific Reports · 2016 · 74 citations · Full text

The miR-644a/CTBP1/p53 axis suppresses drug resistance by simultaneous inhibition of cell survival and epithelial-mesenchymal transition in breast cancer

Umar Raza, Özge Saatci, Stefan Uhlmann et al. · Oncotarget · 2016 · 58 citations · Full text

Epithelial-mesenchymal Transition, Breast Oncology, Oncology +14

Reactivation of cAMP Pathway by PDE4D Inhibition Represents a Novel Druggable Axis for Overcoming Tamoxifen Resistance in ER-positive Breast Cancer

Rasmi R. Mishra, Nevin Belder, Suhail A. Ansari et al. · Clinical Cancer Research · 2018 · 55 citations · Full text

Concurrent Proinflammatory and Apoptotic Activity of a Helicobacter pylori Protein (HP986) Points to Its Role in Chronic Persistence

Ayesha Alvi, Suhail A. Ansari, Nasreen Z. Ehtesham et al. · PLoS ONE · 2011 · 38 citations · Full text

Dysbiosis, Inflammatory Lung Disease, Microbial Pathogens +23